United Interest Expense vs Income Tax Expense Analysis

UTHR Stock  USD 229.72  13.55  5.57%   
United Therapeutics financial indicator trend analysis is much more than just breaking down United Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether United Therapeutics is a good investment. Please check the relationship between United Therapeutics Interest Expense and its Income Tax Expense accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.

Interest Expense vs Income Tax Expense

Interest Expense vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of United Therapeutics Interest Expense account and Income Tax Expense. At this time, the significance of the direction appears to have no relationship.
The correlation between United Therapeutics' Interest Expense and Income Tax Expense is 0.0. Overlapping area represents the amount of variation of Interest Expense that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of United Therapeutics, assuming nothing else is changed. The correlation between historical values of United Therapeutics' Interest Expense and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Interest Expense of United Therapeutics are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Interest Expense i.e., United Therapeutics' Interest Expense and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

0.0
Relationship DirectionFlat 
Relationship StrengthInsignificant

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Income Tax Expense

Most indicators from United Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into United Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.As of 03/28/2024, Selling General Administrative is likely to drop to about 207.3 M. In addition to that, Discontinued Operations is likely to drop to 5,600
 2021 2022 2023 2024 (projected)
Gross Profit1.6B1.8B2.1B2.2B
Total Revenue1.7B1.9B2.3B2.4B

United Therapeutics fundamental ratios Correlations

0.840.240.641.00.97-0.140.97-0.220.850.990.330.920.740.240.560.89-0.30.890.990.920.460.950.990.830.48
0.840.270.370.80.80.260.8-0.250.610.860.20.90.430.130.820.77-0.30.920.80.840.40.820.790.820.51
0.240.27-0.240.220.23-0.180.330.020.330.210.540.420.440.080.510.29-0.550.270.260.230.390.140.190.40.09
0.640.37-0.240.630.69-0.310.57-0.190.610.630.230.360.690.45-0.090.560.020.580.620.480.420.530.650.470.24
1.00.80.220.630.96-0.190.98-0.220.860.980.330.90.740.20.510.88-0.310.850.990.910.420.950.990.810.47
0.970.80.230.690.96-0.180.94-0.150.850.960.430.860.790.40.530.84-0.310.90.960.920.610.880.960.820.55
-0.140.26-0.18-0.31-0.19-0.18-0.260.12-0.59-0.04-0.57-0.01-0.58-0.10.39-0.160.410.12-0.23-0.01-0.270.06-0.170.130.03
0.970.80.330.570.980.94-0.26-0.280.910.940.490.920.780.110.540.91-0.50.830.980.920.450.890.940.750.54
-0.22-0.250.02-0.19-0.22-0.150.12-0.28-0.3-0.19-0.14-0.3-0.210.41-0.11-0.330.34-0.2-0.26-0.130.06-0.2-0.20.020.05
0.850.610.330.610.860.85-0.590.91-0.30.790.630.770.860.20.350.8-0.560.690.890.740.540.680.830.570.41
0.990.860.210.630.980.96-0.040.94-0.190.790.270.90.690.260.580.84-0.250.910.950.920.440.930.970.860.49
0.330.20.540.230.330.43-0.570.49-0.140.630.270.370.660.070.210.42-0.860.310.380.440.650.120.260.140.57
0.920.90.420.360.90.86-0.010.92-0.30.770.90.370.610.110.790.88-0.440.90.910.890.450.890.880.760.44
0.740.430.440.690.740.79-0.580.78-0.210.860.690.660.610.390.210.73-0.480.630.770.590.640.540.740.560.26
0.240.130.080.450.20.4-0.10.110.410.20.260.070.110.390.120.080.360.390.220.130.70.160.310.4-0.07
0.560.820.51-0.090.510.530.390.54-0.110.350.580.210.790.210.120.53-0.320.750.530.620.430.580.50.60.35
0.890.770.290.560.880.84-0.160.91-0.330.80.840.420.880.730.080.53-0.460.810.920.80.40.860.860.650.39
-0.3-0.3-0.550.02-0.31-0.310.41-0.50.34-0.56-0.25-0.86-0.44-0.480.36-0.32-0.46-0.25-0.35-0.44-0.29-0.14-0.21-0.07-0.54
0.890.920.270.580.850.90.120.83-0.20.690.910.310.90.630.390.750.81-0.250.850.840.590.830.860.820.46
0.990.80.260.620.990.96-0.230.98-0.260.890.950.380.910.770.220.530.92-0.350.850.890.460.940.970.780.45
0.920.840.230.480.910.92-0.010.92-0.130.740.920.440.890.590.130.620.8-0.440.840.890.460.880.880.760.73
0.460.40.390.420.420.61-0.270.450.060.540.440.650.450.640.70.430.4-0.290.590.460.460.30.460.460.32
0.950.820.140.530.950.880.060.89-0.20.680.930.120.890.540.160.580.86-0.140.830.940.880.30.940.810.42
0.990.790.190.650.990.96-0.170.94-0.20.830.970.260.880.740.310.50.86-0.210.860.970.880.460.940.820.37
0.830.820.40.470.810.820.130.750.020.570.860.140.760.560.40.60.65-0.070.820.780.760.460.810.820.35
0.480.510.090.240.470.550.030.540.050.410.490.570.440.26-0.070.350.39-0.540.460.450.730.320.420.370.35
Click cells to compare fundamentals

United Therapeutics Account Relationship Matchups

United Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets3.9B4.6B5.2B6.0B7.2B7.5B
Other Current Liab39.6M319.2M301.6M339.1M71M116.3M
Total Current Liabilities463M323.3M305.4M343.2M804.4M844.6M
Total Stockholder Equity2.8B3.4B4.0B4.8B6.0B6.3B
Property Plant And Equipment Net738.5M731.6M780.9M861.5M1.0B1.1B
Net Debt111.6M61.3M(94.8M)(161.2M)(507.7M)(482.3M)
Retained Earnings3.3B3.8B4.3B5.0B6.0B6.3B
Accounts Payable23.1M9.9M4.1M3.8M5.6M10.2M
Cash738.4M738.7M894.8M961.2M1.2B1.3B
Non Current Assets Total2.0B2.4B2.8B2.7B3.6B3.8B
Non Currrent Assets Other154.6M169.9M108.2M114.3M151.8M91.5M
Cash And Short Term Investments2.3B3.0B3.6B4.2B3.0B3.1B
Net Receivables151.4M157.4M198.7M220.4M278.9M292.8M
Common Stock Shares Outstanding43.8M44.6M47.3M48.5M49.7M50.7M
Liabilities And Stockholders Equity3.9B4.6B5.2B6.0B7.2B7.5B
Non Current Liabilities Total670M896.5M904.8M904.6M377.8M269.4M
Other Current Assets133.8M88.3M100.4M219.2M166.2M174.5M
Other Stockholder Equity(531.3M)(430.5M)(333.8M)(190.8M)(30.2M)(28.7M)
Total Liab1.1B1.2B1.2B1.2B1.2B1.2B
Total Current Assets1.9B2.2B2.3B3.4B3.6B3.7B
Short Term Investments747.5M1.1B1.0B1.9B1.8B1.9B
Property Plant And Equipment Gross738.5M731M1.1B1.2B1.5B1.5B
Intangible Assets130.3M130.1M16.6M16.5M80.5M84.5M
Other Liab67M79.4M104.8M76.8M88.3M60.5M
Other Assets293.8M1.6B370.1M413.5M475.5M284.7M
Inventory93.4M86.5M93.8M102M111.8M55.9M
Property Plant Equipment738.5M731.6M780.9M861.5M990.7M1.0B
Net Tangible Assets2.6B3.2B3.9B4.8B5.5B5.7B
Retained Earnings Total Equity3.3B3.8B4.3B5.0B5.8B6.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether United Therapeutics is a strong investment it is important to analyze United Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact United Therapeutics' future performance. For an informed investment choice regarding United Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in United Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
To learn how to invest in United Stock, please use our How to Invest in United Therapeutics guide.
Note that the United Therapeutics information on this page should be used as a complementary analysis to other United Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for United Stock analysis

When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is United Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of United Therapeutics. If investors know United will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about United Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.626
Earnings Share
19.8
Revenue Per Share
49.733
Quarterly Revenue Growth
0.251
Return On Assets
0.1122
The market value of United Therapeutics is measured differently than its book value, which is the value of United that is recorded on the company's balance sheet. Investors also form their own opinion of United Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is United Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because United Therapeutics' market value can be influenced by many factors that don't directly affect United Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between United Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if United Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, United Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.